...Inherited Metabolic Diseases. The product is a recombinant human non-phosphorylated alpha-galactosidase A produced in moss. greenovation...

...world's first GMP-compliant batch of drug substance manufactured in moss for clinical use. The substance, greenovation's...
...treat Fabry's disease. greenovation uses its eukaryotic Physcomitrella-based BryoTechnology platform to develop custom protein biopharmaceuticals. greenovation...

...CSL after development of the first humanized candidate (see BioCentury, Feb. 11). Separately, Arana and greenovation...
...Arana will use its Superhumanization and EvoGene protein engineering technologies to generate optimized drug candidates. greenovation...
...not disclosed. Arana Therapeutics Ltd. (ASX:AAH; LSE:AAHX), North Ryde, Australia CSL Ltd. (ASX:CSL), Melbourne, Australia greenovation...

...in plants. greenovation will license IP from DOW covering modifications of glycosylation patterns in plants. greenovation...
...plant-specific sugar residues in moss. DOW will receive greenovation's data on the work in moss. greenovation...

...in plants. greenovation will license IP from DOW covering modifications of glycosylation patterns in plants. greenovation...
...greenovation will use its double-knock-out technology on plant-specific sugar residues in moss. DOW will receive greenovation's...

...inventors of golden rice at the Swiss Federal Institute of Technology announced a collaboration with Greenovation...

...inventors of golden rice at the Swiss Federal Institute of Technology announced a collaboration with Greenovation...

...AZN received an exclusive license from Greenovation to Golden Rice, a genetically modified rice with high...
...be available for local planting and consumption in 2003. AstraZeneca plc (LSE:AZN; AZN), London, U.K. Greenovation...